Prof. Enrico Roda

Villa Maria Hospital Group, Italy

 

Email: enrico.roda@unibo.it

 

Qualifications

 

1977 2 post-PhD in hepatology obtained at the Royal Free Hospital in London

1974 Master in Digestive Diseases

1971 Master in Internal Medicine

1966 Degree in Medicine and Surgery, University of Bologna, Faculty of Medicine and Surgery

 

Publications (Selected)

1. Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease.Lanzoni G, Alviano F, Marchionni C, Bonsi L, Costa R, Foroni L, Roda G, Belluzzi A, Caponi A, Ricci F, Luigi Tazzari P, Pagliaro P, Rizzo R, Lanza F, Roberto Baricordi O, Pasquinelli G, Roda E, Paolo Bagnara G. Cytotherapy. 2009: 11(8):1020-31.
2. G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence. Lodato F, Azzaroli F, Tamè MR, Di Girolamo M, Buonfiglioli F, Mazzella N, Cecinato P, Roda E, Mazzella G. World J. Gastroenterol. 2009 Nov 21; 15(43):5449-54.
3. Pilot study: the use of sulfasalazine for the treatment of acute pouchitis. Belluzzi A, Serrani M, Roda G, Bianchi ML, Castellani L, Grazia M, Rosati G, Ugolini G, Roda E. Aliment Pharmacol Ther. 2010 Jan 15; 31(2):228-32.
4. Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study. Biselli M, Gramenzi A, Del Gaudio M, Ravaioli M, Vitale G, Gitto S, Grazi GL, Pinna AD, Andreone P, Bernardi M; Bologna Liver Transplantation Group. J Clin Gastroenterol. 2010 Jan; 44(1):52-7.
5. Severe cholestatic acute hepatitis following azathioprine therapy in a patient with ulcerative pancolitis.Roda G, Caponi A, Belluzzi A, Roda E. Dig Liver Dis. 2009 Dec;41(12):914-5.
6. Generation of a novel antibody probe to the apical sodium-dependent bile acid transporter that inhibits ileal bile acid absorption.Montagnani M, Marangoni A, Roda A, Azzaroli F, Mazzella G, Roda E, Tsivian M, Neri F, Jovani M, Giandinoto M, Caponi A, Aldini R.Mol Pharm. 2009 May-Jun;6(3):1012-8.
7. Are therapeutic doses of ursodeoxycholic acid in the cure of primary biliary cirrhosis inadequate? Some clinical considerations.Caponi A, Lisotti A, Grenci C, Roda E. Minerva Gastroenterol Dietol. 2008 Dec; 54(4):331-4.
8. The management of NSAIDs therapy: how to minimize upper gastrointestinal tract damage.Lisotti A, Grenci C, Caponi A, Roda E. Minerva Gastroenterol Dietol. 2008 Dec;54(4):323-9.
9. Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project).Festi D, Dormi A, Capodicasa S, Staniscia T, Attili AF, Loria P, Pazzi P, Mazzella G, Sama C, Roda E, Colecchia A. World J Gastroenterol. 2008 Sep 14;14(34):5282-9.
10. Inflammatory bowel disease: Moving toward a stem cell-based therapy. Lanzoni G, Roda G, Belluzzi A, Roda E, Bagnara GP. World J. Gastroenterol. 2008 Aug 7;14(29):4616-26. Review.
11. Development and validation of a HPLC-ESI-MS/MS method for the determination of 5-aminosalicylic acid and its major metabolite N-acetyl-5-aminosalicylic acid in human plasma. Pastorini E, Locatelli M, Simoni P, Roda G, Roda E, Roda A. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 1;872(1-2):99-106.
12. Clinical efficacy and effectiveness of ursodeoxycholic acid in cholestatic liver diseases. Festi D, Montagnani M, Azzaroli F, Lodato F, Mazzella G, Roda A, Di Biase AR, Roda E, Simoni P, Colecchia A. Curr Clin Pharmacol. 2007 May; 2(2):155-77. Review.
13. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Yeomans N, Lanas A, Labenz J, van Zanten SV, van Rensburg C, Rácz I, Tchernev K, Karamanolis D, Roda E, Hawkey C, Nauclér E, Svedberg LE. Am. J. Gastroenterol. 2008 Oct;103(10):2465-73.
14. Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation. Lodato F, Berardi S, Gramenzi A, Mazzella G, Lenzi M, Morelli MC, Tame MR, Piscaglia F, Andreone P; Bologna Liver Transplantation Group (BLTG), Ballardini G, Bernardi M, Bianchi FB, Biselli M, Bolondi L, Cescon M, Colecchia A, D'Errico A, Del Gaudio M, Ercolani G, Grazi GL, Grigioni W, Lorenzini S, Pinna AD, Ravaioli M, Roda E, Sama C, Vivarelli M. Aliment Pharmacol Ther. 2008 Aug 15; 28(4):450-7.
15. Proton pump inhibitors in cirrhosis: tradition or evidence based practice? Lodato F, Azzaroli F, Di Girolamo M, Feletti V, Cecinato P, Lisotti A, Festi D, Roda E, Mazzella G. World J Gastroenterol. 2008 May 21;14(19):2980-5. Review.
16. Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators.Radaelli F, Meucci G, Sgroi G, Minoli G; Italian Association of Hospital Gastroenterologists (AIGO). Am. J. Gastroenterol. 2008 May; 103(5):1122-30.
17. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova S, Farahmand BY, Winchester CC, Roda E, Bazzoli F. Gut. 2008 Oct;57(10):1354-9.
18. Colonoscopy practice in Italy: a prospective survey on behalf of the Italian Association of Hospital Gastroenterologists. Radaelli F, Meucci G, Minoli G; Italian Association of Hospital Gastroenterologists (AIGO).Dig Liver Dis. 2008 Nov;40(11):897-904.
19. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis. Nanni P, Parisi D, Roda G, Casale M, Belluzzi A, Roda E, Mayer L, Roda A. Rapid Commun Mass Spectrom. 2007;21(24):4142-8
20. Clinical trial: modulation of human placental multidrug resistance proteins in cholestasis of pregnancy by ursodeoxycholic acid. Azzaroli F, Mennone A, Feletti V, Simoni P, Baglivo E, Montagnani M, Rizzo N, Pelusi G, DE Aloysio D, Lodato F, Festi D, Colecchia A, Roda E, Boyer JL, Mazzella G. Aliment Pharmacol Ther. 2007 Oct 15;26(8):1139-46
21. Results of endoscopic retrograde cholangiopancreatography in the treatment of biliary tract complications after orthotopic liver transplantation: our experience. Solmi L, Cariani G, Leo P, Miracolo A, Nigro G, Roda E. Hepatogastroenterology. 2007 Jun; 54(76):1004-8.
22. Endoloop-assisted polypectomy for large peduncolated colorectal polyps. Cariani G, Di Marco M, Roda E. Surg Endosc. 2007 Sep;21(9):1676-7. No abstract available.
23. A new iron free treatment with oral fish cartilage polysaccharide for iron deficiency chronic anemia in inflammatory bowel diseases: a pilot study.Belluzzi A, Roda G, Tonon F, Soleti A, Caponi A, Tuci A, Roda A, Roda E. World J Gastroenterol. 2007 Mar 14; 13(10):1575-8.
24. A new oral formulation for the release of sodium butyrate in the ileo-cecal region and colon. Roda A, Simoni P, Magliulo M, Nanni P, Baraldini M, Roda G, Roda E. World J Gastroenterol. 2007 Feb 21;13(7):1079-84.
25. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease.Colecchia A, Vestito A, Pasqui F, Mazzella G, Roda E, Pistoia F, Brandimarte G, Festi D. World J Gastroenterol. 2007 Jan 14; 13(2):264-9.
26. Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Courtney ED, Matthews S, Finlayson C, Di Pierro D, Belluzzi A, Roda E, Kang JY, Leicester RJ. Int J Colorectal Dis. 2007 Jul; 22(7):765-76.
27. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. Lodato F, Mazzella G, Festi D, Azzaroli F, Colecchia A, Roda E. World J Gastroenterol. 2006 Dec 7;12(45):7239-49. Review.